Stockreport

Poxel Announces Agreement with OrbiMed to Monetize a portion of TWYMEEG® Royalties for USD 50 million [Yahoo! Finance]

SUMITOMO CHEM UNSP/ADR  (SOMMY) 
NASDAQ:AMEX Investor Relations: sumitomo-chem.co.jp/english/ir
PDF In return OrbiMed to obtain the royalties received by Poxel from sales by Sumitomo Pharma of TWYMEEG ® in Japan for a total amount of USD 100 million Rights to royalt [Read more]